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Abstract
Background
Bloodstream infection is a common cause of morbidity in children aged <5 years in develop-
ing countries. In studies reporting bacteremia in Africa, coagulase-negative Staphylococci
(CoNS) are commonly isolated. However, it is currently unclear whether children who are
highly susceptible to infection because of severe acute malnutrition (SAM) or HIV should be
treated with antimicrobials specifically to cover CoNS. We aimed to determine the clinical
significance of CoNS amongst children admitted to a rural hospital in Kenya in relation to
nutritional and HIV status.
Methods
Systematically collected clinical and microbiological surveillance data from children aged
6–59 months admitted to Kilifi County Hospital (2007–2013) were analysed. Multivariable
regression was used to test associations between CoNS isolation from blood cultures and
SAM (MUAC <11.5cm or nutritional oedema (kwashiorkor)), and HIV serostatus; and
among children with SAM or HIV, associations between CoNS isolation and mortality, dura-
tion of hospitalization and clinical features.
Results
CoNS were isolated from blood culture in 906/13,315 (6.8%) children, of whom 135/906
(14.9%) had SAM and 54/906 (6.0%) were HIV antibody positive. CoNS isolation was not
associated with SAM (MUAC<11.5cm (aOR 1.11, 95% CI 0.88–1.40) or kwashiorkor (aOR
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0.84, 95% CI 0.48–1.49)), or a positive HIV antibody test (aOR 1.25, 95% CI 0.92–1.71).
Among children with SAM or a positive HIV antibody test, CoNS isolation was not associ-
ated with mortality or prolonged hospitalization.
Conclusion
In a large, systematic study, there was no evidence that antimicrobial therapy should specifi-
cally target CoNS amongst children with SAM or HIV-infection or exposure.
Introduction
Infections are amongst the leading causes of morbidity and mortality in children under the age
of five years in developing countries despite recent advances in preventive and therapeutic
interventions such as vaccines and antimicrobial drugs.[1] Several studies have been con-
ducted in developing countries aimed at determining the causes of bacteraemia in children
aged<5 years.[2–6] Findings from these studies have guided vaccine introduction and man-
agement of paediatric bacteremia in these settings. However, there still remains a paucity of
comprehensive data of potential pathogens causing invasive disease in children in many areas
since most health care facilities lack adequate microbiological diagnostic capacity.[3]
Studies of the causes of bacteraemia in hospitalised young children in developing countries
have reported that cogulase-negative Staphylococci (CoNS) are frequent blood culture isolates.
[2–13] CoNS are variably reported as ‘culture contaminants’ [2, 5–7, 9, 10] or true pathogens.
[7, 8, 11–13] However, CoNS are common skin and mucous membranes commensal flora,[14]
with relatively low virulence, but possess factors that aid in adherence, biofilm formation, tis-
sue colonization and immune evasion.[15, 16] CoNS are recognized as a cause of clinically sig-
nificant infections, mostly in preterm infants[17], in critically ill patients with indwelling
medical devices[15, 17–19] and in immunocompromised states.[7, 8] It is unknown if CoNS
may cause clinically significant infection in children in sub-Saharan Africa with severe acute
malnutrition (SAM) and human immunodeficiency virus (HIV) infection who are at an
increased risk of serious invasive infection and mortality.[7, 11, 12, 20–24]
One published report from Jamaica has suggested that CoNS are important pathogens
amongst children with SAM, and are associated with respiratory signs;[8] and this is refer-
enced in national guidelines for the management of SAM, designed for health facilities that do
not have access to microbiological diagnosis.[25] WHO recommends penicillin or ampicillin
and gentamicin as first-line antibiotics for complicated severe malnutrition and HIV infected
children suspected to have invasive disease. WHO also recommend that teatment regimens
need to be adapted to local resistance patterns.[26] A separate study done in Jamaica reported
that 6/15 (40%) of blood cuture isolates from 150 severely malnourished children were CoNS,
with greater sensitivity to amoxicillin-clavulanic acid than to crystalline penicillin, suggesting
that current empiric antimicrobial therapy could be improved.[27] If CoNS are common path-
ogens in SAM or HIV, then specific treatment with agents such as vacomycin, daptomycin or
teicoplanin may be warranted since resistance to beta lactam antibiotics has been demon-
strated.[28] Currently, limited data and inconsistent reporting mean that the clinical signifi-
cance of CoNS is unclear.
To resolve the question of whether CoNS is clinically significant amongst hospitalized
children with SAM and/or HIV infection in Africa, we undertook a retrospective analysis
of a large systematically collected clinical and microbiological surveillance dataset from
CoNS in Kenyan children with SAM or HIV
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hospitalized children in rural Kenya. We aimed to describe the association of CoNS isolation
with SAM and HIV status, and association in these groups with clinical signs, mortality, and
duration of hospitalization.
Methods
Location and participants
The study was conducted at Kilifi County Hospital (KCH), located at the Kenyan coast and
serving a mainly rural population of low social economic status. Children requiring hospitali-
zation are admitted to either the general pediatric ward or high dependency unit (HDU)
which provides close patient monitoring, but does not have capacity for central venous cathe-
ters, arterial lines, parenteral nutrition or invasive ventilation.
All pediatric admissions were systematically assessed and investigated with blood cultures
prior to initiation of antibiotics (normally benzylpenicillin or ampicillin plus gentamicin) as
previously described.[2] Children presenting with minor trauma or those scheduled for elec-
tive surgery did not have blood cultures done and were therefore not included in this analysis.
HIV testing was offered to all admissions by trained counsellors, as per Kenya national guide-
lines.[29] HIV serologic testing was performed using a standard algorithm after consent was
obtained from parents or guardians. A positive serologic test [KHB Colloidal Gold (KHB
Shanghai Keshaun Bio-engineering Co, Shanghai, China)] was confirmed by a second sero-
logic test [First Response™ 1–2.0 (PMC Medical Pty. Ltd, Daman, India)]. Children with HIV
infection or exposure and their families were counselled and referred to the hospital’s HIV
clinic for further investigation, management and follow-up. Confirmatory HIV test results by
PCR were not consistently available, and we therefore used HIV serologic results for the analy-
sis. Medical care is provided according to World Health Organization (WHO) guidelines for
fluids, antimicrobials, nutritional therapy for SAM and other components of supportive care.
[26] Clinical and laboratory data were entered routinely onto an electronic data entry system.
All children aged between 6 and 59 months admitted to KCH between January 2007 and
December 2013 with blood culture results available were eligible for inclusion into this
analysis.
Clinical definitions
All children underwent anthropometry at admission. SAM was classified according to WHO by
the presence of kwashiorkor (nutritional edema), or by mid-upper arm circumference (MUAC)
<11.5cm.[26] Features of respiratory distress included nasal flaring, chest wall indrawing, diffi-
culty in breathing, deep respirations, hypoxia or tachypnea. Hypoxia was defined as an oxygen
saturation90% in room air using pulse oximetry. Tachypnea was defined as a respiratory rate
50 breaths per minute in children aged<12 months, and40 breaths per minute in children
aged 12–59 months.[26] Impaired consciousness was defined as Blantyre Coma Scale<4 in
children up to 9 months and<5 in children aged9 months.[30]
Microbiologic methods
Blood samples for culture were collected on admission after children’s skin was cleaned with
70 percent ethanol and allowed to dry as previously described.[2] Regular phlebotomy training
was done to reduce blood culture contamination rates. Blood samples were inoculated into
commercial vials containing enriched soybean-casein digest broth with CO2 (BACTEC Peds
Plus/F medium, Becton Dickinson), and incubated in an automated blood culture system
(BACTEC 9050, Becton Dickinson). Manufacturer’s recommended blood volume for culture
CoNS in Kenyan children with SAM or HIV
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is between 0.5 and 5.0 mL, with optimum results obtained for volumes between 1.0 and 3.0
mL. Blood culture vials were weighed before and after sample inoculation to determine the
volume of blood cultured. Culture vials were incubated for 5 days, or until the system indicated
the culture was positive. Aliquots of culture sample from positive vials were Gram-stained and
sub-cultured, and isolates identified by standard microbiological methods.[2] CoNS, Bacillus
species, coryneforms, Micrococcus species, viridans group streptococci and Candida species
were presumed to be contaminants and no targeted therapy for these was given; empiric anti-
biotic therapy was continued based on clinical resolution of illness/recommended WHO
guidelines for use antimicrobials.[26] CoNS species were not determined and CoNS isolates
were not stored or tested for antibiotic susceptibilities. All laboratory procedures were inter-
nally controlled and KEMRI-Wellcome Trust Research Laboratories were externally moni-
tored for quality assurance by the United Kingdom External Quality Assessment Service and
Good Clinical Laboratory Practice (GCLP) accredited by Qualogy, UK.
Statistical analysis
Statistical analysis was performed using STATA version 13 (Stata Corp., College Station, TX,
USA). Data were extracted from the database, checked for any biological implausible measure-
ments that may have resulted from transcription errors, and resolved prior to analysis. Blood
culture results were indicated as no growth, CoNS, other isolates presumed non-pathogenic as
listed above, or bacterial species that are usually regarded as pathogens (referred to from here
as ‘known pathogens’). CoNS were analysed separately from the group of presumed contami-
nants described above. Children with mixed CoNS and presumed contaminants on blood cul-
ture were excluded from this analysis.
Data obtained from initial admission to hospital was included in this analysis; hospital read-
mission data was not included in this analysis.
Children were grouped by sex, nutritional status (MUAC (13.5 cm, 12.5 to 13.4 cm, 11.5
to 12.4 cm, <11.5 cm) or the presence of kwashiorkor) and HIV serologic test result (negative,
positive or not performed).
Continuous variables were described using median and interquartile range (IQR) and com-
pared using a Wilcoxon rank sum test. Categorical variables were described using proportions
and compared using Chi-squared or Fisher’s exact test as appropriate.
Multivariable logistic regression analysis was used to identify putative risk factors of CoNS,
and the association of CoNS with clinical signs and symptoms, and mortality. Multivariable
linear regression was used to assess the association of CoNS with duration of hospitalization
(days). Transformation of age (natural log) and blood volume (square root) was done for the
linear regression models.
Regression models were set up using backward selection; predictors with p<0.05, and pre-
dictors known a priori to act as potential confounders regardless of the p value were included
in the final model. For both logistic and linear regression models, adjustment for a priori con-
founders: age, sex and volume of blood culture was done. Inadequate blood samples for culture
may increase the likelihood of isolation of CoNS and presumed contaminants, especially in
younger children and severely malnourished children with difficult venipuncture. SAM, HIV
and malaria are associated with mortaliy in hospitalized children hence these variables were
adjusted for in the regression models. Clinical features found to have a p value of0.1 on uni-
variable regression were entered into multivariable regression models to determine the associ-
ation of CoNS with clinical presentation at admission.
The primary analysis compared children with CoNS isolated to all other children, since the
presence of CoNS may have masked growth of known pathogens. As secondary analyses, we
CoNS in Kenyan children with SAM or HIV
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also compared children with CoNS isolated to those with no growth on blood cultures, and
blood culture isolation of CoNS versus known pathogens. Comparison of children with CoNS
to children with presumed contaminants was also done. Sub-group analyses of the relationship
between CoNS isolation and HIV status above and below 18 months of age were done as a pos-
itive antibody test above 18 months confirms HIV infection, whilst under 18 months, infection
and maternal exposure may not be distinguished.
Ethical considerations
This study was approved by the Kenya Medical Research Institute’s Ethical Review Committee,
Nairobi (SSC/ERC 2906). This analysis was a retrospective review of admissions to hospital
based on routine clinical data and laboratory findings.
Results
Participants and blood culture isolates
Overall, 13,315 children were included in the study (S1 Fig) of whom 1,710 (12.8%) had SAM,
and 643 (4.8%) had a positive HIV antibody test (Table 1). CoNS were isolated from blood cul-
ture in 906 (6.8%) children, known pathogens were isolated from 564 (4.2%) and 11,044
(82.9%) children had no growth on blood cultures. Presumed contaminants were isolated
from blood culture in 801(6.0%) children. 1,714/2,301 (74.5%) of all blood culture isolates
were either CoNS or presumed contaminants. 23 children had more than one organism iso-
lated from blood culture (Table 2). None of culture results had CoNS/presumed contaminants
isolated together with known pathogens. CoNS isolation declined during the period studied
(Table 3).
Median blood volume cultured was 0.8ml (IQR 0.4–1.3ml) amongst children with CoNS,
1.0ml (IQR 0.5–1.7ml) amongst children with no growth on culture, 0.7ml (IQR 0.3–1.1ml)
amongst children with presumed non-pathogenic isolates, and 1.0ml (IQR 0.5–1.7ml)
amongst children with known pathogens (S1 Table). The median blood volume cultured was
similar in children with CoNS to all others amongst children with SAM [0.8ml (IQR 0.4–
1.5ml]) vs. 0.9ml (IQR 0.4–1.6ml), p = 0.10], and amongst children with positive HIV antibody
test [0.7ml (IQR 0.3–1.3ml) vs. 0.9ml (IQR 0.4–1.4ml), p = 0.51]. Time to culture positivity
amongst children with CoNS (16.2 hours, IQR 14.6–18.4) was less than amongst children with
presumed contaminants (36.7 hours, IQR 14.5–65.0), p<0.001.
All children had a blood smear for malaria parasites done at admission with 2,198/13,315
(16.5%) being positive. Although the prevalence of malaria amongst children with CoNS [126/
906 (13.9%)] differed from children with either no growth [1,912/11,044 (17.3%), p = 0.01] or
known pathogens [42/564 (7.5%), p<0.001], it was similar to prevalence of malaria amongst
children with presumed contaminants [118/801 (14.7%), p = 0.63].
Association between CoNS and SAM
The prevalence of SAM was similar between children with CoNS and all other children (14.9%
vs. 12.7%, p = 0.16). There was no evidence of an association between either low MUAC or
kwashiorkor and CoNS isolation (S2 Table and Table 3) in multivariable analyses, adjusting
for age, sex, blood volume sampled, HIV status, malaria, and year of admission.
Low nutritional status had a strong negative association with isolation of CoNS versus
known pathogens [MUAC<11.5cm (aOR 0.65, 95% CI 0.45–0.92) and kwashiorkor (aOR
0.26, 95% CI 0.13–0.54)] (Table 3).
CoNS in Kenyan children with SAM or HIV
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Association between CoNS and HIV
HIV status did not differ between children with CONS [6.0% (n = 25 aged <18 months and
n = 29 aged18 months)] and those without CoNS [4.8% (n = 236 aged<18 months and
n = 353 aged18 months), p = 0.22]. Thus, HIV antibody positivity was not associated with
CoNS compared with all other children (aOR 1.25, 95% CI 0.92–1.71) (Table 3).
However, HIV antibody positivity was more common amongst children with CoNS than in
those with negative cultures, (aOR 1.49, 95% CI 1.09–2.04) but much less common in children
with CoNS than in those with known pathogens (aOR 0.31, 95% CI 0.21–0.45) (Table 3).
Association between CoNS and outcomes in children with SAM or HIV
Amongst children with SAM and children with HIV, there was no association between isola-
tion of CoNS and mortality compared to all other children or children with no growth on
Table 1. Characteristics of study participants.
Characteristic All children
(n = 13,315)a
No SAM and HIV
(n = 10,171)
SAM only
(n = 1,382)
HIV only
(n = 315)
SAM and HIV
(n = 328)
P valueb
Age, monthsc 20.0 (11.8–33.5) 20.4 (12.2–34.2) 14.7 (9.6–23.7) 25.8 (15.0–
39.6)
19.0(12.4–27.9) <0.001
Femaled 5,804 (43.6) 4,343 (42.7) 671 (48.6) 139 (44.1) 156 (47.6) <0.001
Weight, kgc 8.8 (7.2–11.0) 9.2 (7.7–11.3) 6.0 (5.2–7.2) 8.8 (7.1–10.5) 6.0 (5.1–6.9)b <0.001
Height, cmc 77.5 (71.0–86.7) 78.5 (72.0–87.7) 70.0 (65.0–76.0) 79.5 (72.4–
87.0)
72.0 (66.5–78.0)b <0.001
MUAC, cmc 13.5 (12.5–14.6) 14.0 (13.0–15.0) 11.0 (10.0–11.2) 13.0 (12.0–
14.0)
10.0 (9.3–11.0)b <0.001
SAM
MUAC <11.5 cmd 1,455 (10.9) 0 (0) 1,136 (82.2) 0 (0) 319 (97.3) <0.001
Kwashiorkord 255 (1.9) 0 (0) 246 (17.8) 0 (0) 9 (2.7)b
HIV antibody status
Negatived 11,700 (87.9) 10,171 (100) 1,277 (92.4) 0 (0) 0 (0) <0.001
Positived 643 (4.8) 0 (0) 0 (0) 315 (100) 328 (100)
Not testedd 972 (7.3) 0 (0) 105 (7.6) 0 (0) 0 (0)
Blood culture results
No growthd 11,044 (82.9) 8,546 (84.0) 1,114 (80.6) 225 (71.4) 220 (67.1) <0.001
CoNSd 906 (6.8) 671 (6.6) 109 (7.9) 28 (8.9) 26 (7.9)
Known pathogensd 564 (4.2) 321 (3.2) 79 (5.7) 45 (14.3) 68 (20.7)
Presumed
contaminantsd,e
801 (6.0) 633 (6.2) 80 (5.8)b 17 (5.4) 14 (4.3)
Malaria
Negatived 11,117 (83.5) 8,350 (82.1) 1,289 (93.3) 287 (91.1) 317 (96.7) <0.001
Positived 2,198 (16.5) 1,821 (17.9) 93 (6.7) 28 (8.9) 11 (3.3)
Died in hospitald 589 (4.4) 229 (2.3) 171 (12.4)) 20 (6.4) 75 (22.9) <0.001
Hospitalization, daysc 3.0 (2.0–7.0) 3.0 (2.0–5.0) 11.0 (7.0–19.0) 7.0 (4.0–11.0) 18.5 (11.5–28.0) <0.001
Abbreviations: CoNS, coagulase-negative staphylococci; IQR, interquartile range; MUAC, mid-upper arm circumference; HIV, human immunodeficiency
syndrome; SAM, severe acute malnutrition.
a Includes 1,119 children of whom i) 802 did not have SAM but missed HIV status, ii) 252 HIV negative but missed nutrition status, and iii) 65 with both
nutrition and HIV status missing.
b Comparison of children without SAM and HIV, children with SAM only, children with HIV only, and children with both SAM and HIV.
c Median (IQR)
d Number (percentage)
e Includes Bacillus species, coryneforms, Micrococcus species, viridans group streptococci, and Candida species.
https://doi.org/10.1371/journal.pone.0182354.t001
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culture (Table 4). Children with CoNS were much less likely to die than children with known
pathogens, amongst children with SAM (aOR 0.26, 95% CI 0.13–0.49) or positive HIV test
(aOR 0.33, 95% CI 0.11–0.98) (Table 4). In both SAM and HIV, children with CoNS were
admitted for a similar duration to all other children without CoNS (Table 4).
Clinical features of CoNS in children with SAM or HIV
Amongst children with SAM, no clinical signs or symptoms at admission were more fre-
quently observed amongst children with CoNS than all other children after adjusting for age,
sex, blood volume sampled, HIV status, malaria, and year of admission (Table 5). Delayed cap-
illary refill was less frequent amongst children with CoNS than amongst all other children.
Compared to children with known pathogens, children with CoNS less frequently presented
with a prolonged capillary refill time (Table 5).
Amongst children with positive HIV antibody test, no clinical features were more frequent
amongst children with CoNS isolation compared with all other children and those with no
Table 2. Blood culture isolates from 13,315 children admitted to Kilifi County Hospital between Jan. 2007-Dec. 2013.
All children (13,315) SAM only (1,382) HIV positive only (315) SAM and HIV positive (328)
Isolates n = 2,301 (%)a n = 246 (%)a n = 87 (%)a n = 117 (%)a
Gram positive 339 (14.7) 35 (14.2) 32 (36.8) 36 (30.8)
Streptococcus pneumoniae 228 (9.9) 25 (10.2) 29 (33.3) 32 (27.4)
Staphylococcus aureus 75 (3.3) 6 (2.4) 2 (2.3) 1 (0.9)
Group A Streptococcus 17 (0.7) 0 (0) 1 (1.1) 2 (1.7)
Group D Streptococcus 9 (0.4) 2 (0.8) 0 (0) 0 (0)
Othersb 10 (0.4) 2 (0.8) 0 (0) 1 (0.9)
Gram negative 248 (10.8) 38 (15.4) 11 (12.6) 40 (34.2)
Escherichia coli 54 (2.3) 13 (5.3) 3 (3.4) 7 (6.0)
Non-typhi Salmonella 53 (2.3) 8 (3.3) 4 (4.6) 14 (12.0)
Acinetobacter sp 38 (1.7) 1 (0.4) 0 (0) 1 (0.9)
Haemophilus influenzae 32 (1.4) 3 (1.2) 3 (3.4) 9 (7.7)
Pseudomonas aeruginosa 13 (0.6) 4 (1.6) 0 7 (6.0)
Klebsiella pneumoniae 10 (0.4) 3 (1.2) 1 (1.1) 1 (0.9)
Salmonella typhi 9 (0.4) 0 (0) 0 (0) 0 (0)
Campylobacter jejuni 6 (0.3) 3 (1.2) 0 (0) 0 (0)
Othersc 33 (1.4) 3 (1.2) 0 (0) 1 (0.9)
CoNS 906 (39.4) 103 (41.9) 27 (31.0) 26 (22.2)
Presumed contaminants 808 (35.1) 70 (28.5) 17 (19.5) 15 (12.8)
Bacillus sp 624 (27.1) 50 (20.3) 13 (14.9) 9 (7.7)
Coryneforms 93 (4.0) 12 (4.9) 2 (2.3) 3 (2.6)
Micrococcus sp 47 (2.0) 3 (1.2) 0 (0) 0 (0)
Streptococcus viridans 39 (1.7) 5 (2.0) 2 (2.3) 3 (2.6)
Candida sp 5 (0.2) 0 (0) 0 (0) 0 (0)
Abbreviations: SAM, severe acute malnutrition; HIV, human immunodeficiency virus; CoNS, coagulase-negative staphylococci.
a Number of isolates (percent): Percentage refers to proportion of isolates in each column (may not sum to 100 due to rounding off).
b Species included streptococci groups C (1), F (4) and G (1), and Streptococcus sp (4).
c Species included Enterobacter sp (5), unidentified Gram negative rods (4), Pseudomonas stutzeri (3), Enterobacter cloacae (2), Moraxella catarrhalis (2),
Neisseria sp (2), Pantoea sp (2), Shigella flexneri (2), Acinetobacter lwoffii (1), Aeromonas sp (1), Bacteroides sp (1), Enterobacter aerogenes (1),
Pseudomonas cepacia (1), Pseudomonas maltophilia (1), Pseudomonas oryzihabitans (1), Pseudomonas vescularis (1), Pseudomonas sp (1), Pasteurella
sp (1), and Shigella sonnei (1).
https://doi.org/10.1371/journal.pone.0182354.t002
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Table 3. Multivariable analysis of associations with CoNS amongst all admissions.
Characteristics CoNS
(n = 906)
Others
(n = 12,409)
No growth
(n = 11,044)
Pathogens
(n = 564)
CoNS vs
Others
CoNS vs No
growth
CoNS vs
Pathogens
aOR (95% CI)a aOR (95% CI)a aOR (95% CI)a
Age, months 17.7 (10.7–
29.9)
20.1 (11.9–
33.7)
20.2 (12.0–
33.9)
17.8 (10.6–
31.0)
0.99 (0.98–
0.99)
0.99 (0.98–0.99) 1.00 (0.99–1.00)
Female 368 (40.6) 5, 436 (43.8) 4,840 (43.8) 235 (41.7) 0.88 (0.77–
1.01)
0.88 (0.76–1.01) 1.05 (0.83–1.32)
Blood volume, ml 0.8 (0.4–1.3) 0.9 (0.5–1.6) 1.0 (0.5–1.7) 1.0 (0.5–1.7) 0.99 (0.89–
1.10)
1.00 (0.90–1.11) 0.76 (0.64–0.90)
Nutritional Status
MUAC, cm
13.5 471 (52.0) 6,595 (53.2) 5,950 (53.9) 212 (37.6) Ref Ref Ref
12.5–13.4 175 (19.3) 2,480 (20.0) 2,219 (20.1) 96 (17.0) 0.91 (0.76–
1.10)
0.91 (0.75–1.10) 0.82 (0.60–1.12)
11.5–12.4 104 (11.5) 1,451 (11.7) 1,261 (11.4) 92 (16.3) 0.90 (0.72–
1.13)
0.93 (0.74–1.17) 0.61 (0.43–0.87)
<11.5 122 (13.5) 1,333 (10.7) 1,132 (10.3) 124 (22.0) 1.11 (0.88–
1.40)
1.15 (0.91–1.45) 0.65 (0.45–0.92)
Oedema 13 (1.4) 242 (2.0) 202 (1.8) 23 (4.1) 0.84 (0.48–
1.49)
0.92 (0.52–1.64) 0.26 (0.13–0.54)
Missing 21 (2.3) 308 (2.4) 280 (2.5) 17 (3.0) 0.82 (0.51–
1.31)
0.78 (0.49–1.24) 0.60 (0.29–1.21)
HIV antibody
status
Negative 791 (87.3) 10,909 (87.9) 9,795 (88.7) 402 (71.3) Ref Ref Ref
Positive 54 (6.0) 589 (4.8) 445 (4.0) 113 (20.0) 1.25 (0.92–
1.71)
1.49 (1.09–2.04) 0.31 (0.21–0.45)
Not tested 61 (6.7) 911 (7.3) 804 (7.3) 49 (8.7) 1.02 (0.77–
1.34)
1.06 (0.80–1.40) 0.64 (0.42–0.97)
Malaria
Negative 780 86.1) 10,337 (83.3) 9,132 82.7) 522 (92.6) Ref Ref Ref
Positive 126 (13.9) 2,072 (16.7) 1,912 (17.3) 42 (7.4) 0.90 (0.74–
1.09)
0.86 (0.70–1.06) 1.91 (1.29–2.82)
Year
2007 253 (27.9) 2,103 (17.0) 1,743 (15.8) 115 (20.4) Ref Ref Ref
2008 211 (23.3) 1,892 (15.2) 1,571 (14.2) 88 (15.6) 0.89 (0.73–
1.09)
0.89 (0.73–1.10) 0.93 (0.65–1.32)
2009 166 (18.3) 2,320 (18.7) 2,047 (18.5) 103 (18.3) 0.59 (0.48–
0.72)
0.55 (0.44–0.67) 0.73 (0.52–1.04)
2010 92 (10.2) 1,952 (15.7) 1,785 (16.2) 109 (19.3) 0.40 (0.31–
0.52)
0.36 (0.28–0.46) 0.43 (0.29–0.63)
2011 83 (9.2) 1,755 (14.1) 1,655 (15.0) 59 (10.5) 0.39 (0.30–
0.51)
0.34 (0.26–0.44) 0.79 (0.51–1.22)
2012 54 (6.0) 1,404 (11.3) 1,321 (12.0) 51 (9.0) 0.32 (0.23–
0.45)
0.28 (0.20–0.39) 0.63 (0.38–1.03)
2013 47 (5.2) 983 (7.9) 922 (8.4) 39 (6.9) 0.41 (0.28–
0.59)
0.35 (0.24–0.51) 0.81 (0.46–1.43)
Abbreviations: CoNS, Coagulase-negative Staphylococci; OR, odds raio; aOR, adjusted odds ratio; CI, confidence interval; MUAC, mid-upper arm
circumference; HIV, human immunodeficiency virus.
a Adjusted for age, sex, blood volume, nutrition status, HIV antibody test, malaria, and year of admission.
https://doi.org/10.1371/journal.pone.0182354.t003
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growth on cultures. Compared to children with known pathogens, children with CoNS were
less likely to present with convulsions (aOR 0.16, 95% CI 0.03–0.86) or impaired consciousness
level (aOR 0.38, 95% CI 0.15–0.97) (Table 6).
Repeated blood cultures
In our study, 26 of the children who had CoNS isolated at admission had repeat blood cultures
because of clinical suspicion of sepsis and poor response to treatment during hospitalization:
14/26 grew CoNS while 6/26 grew known pathogens. 6/26 children died (1 with CoNS) and
had the following characteristics: i) SAM, positive HIV antibody test and known pathogen, ii)
no SAM, positive HIV antibody test and known pathogen, iii) SAM, negative HIV antibody
test and CoNS, iv) SAM and other presumed contaminating isolate, v) negative HIV antibody
and other presumed contaminating isolate, and vi) negative HIV antibody test and known
pathogen on repeat blood culture. As no speciation of culture isolates was done, it was not
known whether repeat CoNS isolates were similar to admission isolates.
Discussion
In rural Kenya, CoNS were commonly isolated from blood culture amongst children admitted
to hospital, as has been reported in several studies in developing countries.[9, 13] However,
CoNS was no more common among children with SAM and/or a positive HIV antibody test
than among other children. CoNS isolation was not associated with inpatient mortality, or
Table 4. Outcomes amongst children with CoNS.
CoNS Others No
growth
Pathogens CoNS vs Others CoNS vs No growth CoNS vs Pathogens
Mortality OR (95% CI) aOR (95%CI) OR (95% CI) aOR (95% CI) OR (95% CI) aOR (95% CI)
All admissionsa 32
(3.5)
557
(4.5)
420
(3.8)
98 (17.4) 0.78 (0.54–
1.12)
0.76 (0.52–
1.10)b
0.93 (0.64–
1.34)
0.92 (0.63–
1.34)b
0.17 (0.11–
0.26)
0.20 (0.13–
0.33)a
SAMa 19
(14.1)
227
(14.4)
149
(11.2)
55 (37.7) 0.97 (0.59–
1.61)
0.95 (0.57–
1.60)c
1.30 (0.78–
2.18)
1.28 (0.76–
2.18)c
0.27 (0.15–
0.49)
0.26 (0.13–
0.49)b
Positive HIV testa 80
(14.8)
87
(14.9)
50
(11.3)
33 (29.1) 1.00 (0.46–
2.19)
0.97 (0.42–
2.22)d
1.36 (0.61–
3.05)
1.42 (0.59–
3.38)d
0.42 (0.18–
0.99)
0.33 (0.11–
0.98)c
Duration of
hospitalization
(survivors), days
β
coefficient
(95% CI)
Adjusted β
coefficient
(95% CI)
β
coefficient
(95% CI)
Adjusted β
coefficient
(95% CI)
β
coefficient
(95% CI)
Adjusted β
coefficient
(95% CI)
All admissionse 3.0
(2.0–
7.0)
3.0
(2.0–
6.0)
3.0
(2.0–
6.0)
8.0 (3.0–
15.0)
0.37 (-0.16–
0.89)
0.24 (-0.24–
0.71)b
0.55 (0.03–
1.07
0.37 (-0.10–
0.84)b
-4.80 (-5.79-
-3.80)
-3.49 (-4.42-
-2.57)b
SAMe 13.0
(8.0–
21.0)
12.0
(7.0–
21.0)
12.0
(7.0–
20.0)
18.0 (12.0–
26.0)
1.22 (-0.97–
3.42)
1.03 (-1.11–
3.16)c
1.57 (-0.64–
3.78)
1.36 (-0.79–
3.50)c
-3.63 (-6.83-
-0.43)
-2.72 (-6.10–
0.67)c
Positive HIV teste 11.0
(6.0–
15.0)
11.0
(5.0–
20.0)
10.0
(5.0–
21.0)
12.0 (6.5–
20.5)
0.01 (-3.78–
3.79)
0.17 (-3.11–
3.45)d
-0.22
(-4.16–3.71)
-0.05 (-3.54–
3.44)d
-0.54
(-5.02–3.94)
0.09 (-3.93–
4.11)d
Abbreviations: CoNS, coagulase-negative staphylococci; OR, odds ratio; CI, confidence interval; aOR, adjusted odds ratio; SAM, severe acute malnutrition;
HIV, human immunodeficiency virus.
a n/N (%), number with variable of interest/total group size (percentage).
b Adjusted for age, sex, blood volume, HIV Ab status, nutrition status, malaria, and year.
c Adjusted for age, sex, blood volume, HIV Ab status, malaria, and year.
d Adjusted for age, sex, blood volume, nutrition status, malaria, and year.
e Median (IQR).
https://doi.org/10.1371/journal.pone.0182354.t004
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prolonged duration of hospitalization amongst those discharged alive. In children with SAM
or HIV there was no clinical phenotype associated with CoNS blood culture isolation. Thus,
take the approach of a large epidemiological study, our findings suggests that CoNS are not
commonly behaving as pathogens in children with HIV or SAM in this setting, and overall do
not warrant targeted empiric first-line therapy. However, we cannot exclude that in a very
small number of individuals CoNS may have been pathogenic.
Our conclusions differ to a study conducted among 336 severely malnourished children in
Jamaica where CoNS [24/69 (35%)] were the most frequent blood culture isolates. CoNS were
reported to be more frequent amongst children with the poorest nutrition status (kwashiorkor
and marasmic kwashiorkor) compared to children with marasmus only. Children with CoNS
were reported to be more likely to have radiographic pneumonic consolidation than children
with bacteremia due to other organisms (8 (22%) p<0.02).[8] CoNS isolation was therefore
considered to be clinically significant requiring appropriate antimicrobial therapy. However,
surprisingly given the other findings, isolation of CoNS was not associated with mortality. The
differences from our study may be due to chance given the small sample size in Jamaica, con-
founding by differential skin contamination or because children were recruited from a differ-
ent population.
CoNS have also been reported as common blood culture isolates and of clinical significance
amongst hospitalized severely malnourished children in Kenya,[11] Ethiopia,[13] and amongst
HIV-infected children in South Africa[12] and Zimbabwe.[7] However, not all of these studies
Table 5. Clinical features of CoNS among 1,710 children with severe acute malnutrition.
Characteristic CoNS
n = 135
Others
n = 1,575
No growth
n = 1,334
Pathogens
n = 147
CoNS vs Others CoNS vs No growth CoNS vs Pathogens
n (%) n (%) n (%) n (%) OR (95%
CI)
aOR (95%
CI)a
OR (95%
CI)
aOR (95%
CI)a
OR (95%
CI)
aOR (95%
CI)b
History of fever 99 (73.3) 1,130
(72.0)
950 (71.4) 117 (80.1) 1.07 (0.72–
1.60)
0.98 (0.63–
1.53)
1.10 (0.74–
1.64)
1.00 (0.65–
1.56)
0.68 (0.39–
1.19)
0.69 (0.36–
1.36)
Temperature
<36.5˚C >37.5˚C
18 (13.3)
67 (49.6)
190 (12.1)
758 (48.2)
162 (12.2)
629 (47.2)
15 (10.2)81
(55.1)
1.19 (0.68–
2.08)1.11
(0.76–1.62)
1.37 (0.77–
2.44)1.04
(0.69–1.56)
1.20 (0.68–
2.12)1.15
(0.79–1.69)
1.35 (0.75–
2.43)1.09
(0.72–1.65)
1.22 (0.56–
2.69)0.84
(0.51–1.40)
1.78 (0.69–
4.59)1.05
(0.58–1.89)
Cough 90 (66.7) 896 (57.1) 741 (55.7) 105 (71.9) 1.50 (1.04–
2.18)
1.28 (0.86–
1.90)
1.59 (1.09–
2.31)
1.34 (0.90–
2.00)
0.78 (0.47–
1.30)
0.93 (0.50–
1.74)
Respiratory
distress
82 (60.7) 875 (55.6) 717 (53.8) 110 (74.8) 1.24 (0.86–
1.77)
1.14 (0.75–
1.71)
1.33 (0.93–
1.91)
1.22 (0.81–
1.84)
0.52 (0.31–
0.86)
0.72 (0.41–
1.30)
Vomiting 42 (31.1) 621 (40.0) 530 (39.9) 56 (38.4) 0.69 (0.47–
1.01)
0.79 (0.51–
1.24)
0.68 (0.47–
0.99)
0.78 (0.49–
1.23)
0.73 (0.44–
1.19)
0.82 (0.46–
1.45)
Diarrhea 51 (37.8) 729 (46.4) 614 (46.2) 68 (46.6) 0.70 (0.49–
1.01)
0.81 (0.53–
1.25)
0.71 (0.59–
1.01)
0.82 (0.53–
1.28)
0.70 (0.43–
1.12)
0.80 (0.46–
1.40)
Inability to drink 4 (3.1) 33 (2.1) 26 (2.0) 6 (4.2) 1.46 (0.51–
4.20)
1.44 (0.47–
4.40)
1.58 (0.54–
4.59)
1.38 (0.44–
4.34)
0.74 (0.20–
2.67)
1.06 (0.24–
4.74)
Capillary refill
time,3 sec
2 (1.5) 107 (6.8) 79 (6.0) 19 (13.0) 0.21 (0.05–
0.85)
0.23 (0.05–
0.95)
0.24 (0.06–
0.99)
0.25 (0.06–
1.07)
0.10 (0.02–
0.45)
0.17 (0.04–
0.80)
Convulsions 8 (5.9) 58 (3.7) 44 (3.3) 13 (8.9) 1.64 (0.77–
3.52)
1.76 (0.75–
4.10)
1.84 (0.85–
4.00)
2.11 (0.88–
5.07)
0.64 (0.26–
1.61)
0.77 (0.26–
2.23)
Impaired
consciousness
37 (27.6) 376 (24.0) 297 (22.4) 59 (40.4) 1.21 (0.81–
1.79)
1.35 (0.88–
2.09)
1.32 (0.88–
1.97)
1.46 (0.94–
2.26)
0.56 (0.34–
0.93)
0.63 (0.35–
1.14)
a Adjusted for age, sex, blood volume, HIV status, malaria, year, and clinical features with p0.1 at univariable regression (cough, vomiting, diarrhea and
prolonged capillary refill time).
b Adjusted for age, sex, blood volume, HIV status, malaria, year, and clinical features with p0.1 (respiratory distress, prolonged capillary refill time and
impaired consciousness).
https://doi.org/10.1371/journal.pone.0182354.t005
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examined clinical outcomes.[11, 12] Others have reported CoNS as ‘contaminants’ in immu-
nocompromised children. Of 846 blood cultures sampled from 461 HIV-infected children in
Uganda and Zimbabwe, CoNS [12/127 (9.4%)] were the commonest isolates amongst symp-
tomatic children, but regarded as of ‘doubtful pathogenicity’.[9] CoNS was isolated from 19/38
(50%) of blood culture isolates obtained from 140 severely ill Gambian children with SAM, of
whom 27 were HIV-infected. This study was too small to determine an association between
CoNS and HIV.[10] One study in Zimbabwe classified pathogenicity of CoNS based on time
to positivity <3 days, presence of elevated temperature >38˚C or leukocytosis >15x109/liter.
Amongst 309 hospitalized children, of whom 168 (54%) were HIV infected, CoNS was the
commonest blood culture isolate in all children [31/99 (31%)], and also those who were HIV
infected [17/67 (25%)]. Overall, 25/31 (81%) CoNS isolates were assumed to be clinically sig-
nificant, but again were not associated with mortality.[7]
These findings from resource-poor settings similar to ours reflect the challenges of whether
or not to institute definitive management based on interpretation of culture results. Determining
whether CoNS are clinically significant in an individual child remains challenging, even when
culture facilties exist. For this reason, we chose to examine the risks for CoNS and its outcomes
in a large population of sick children in order to inform guidelines used in the vast majority of
settings where sick children are treated that do not have access to microbiological diagnosis.
Our study primarily compared children with CoNS to all other children because CoNS may
have masked the growth of known pathogens. In addition, we compared children with CoNS
Table 6. Clinical features of CoNS among 643 children with a positive HIV antibody test.
Characteristic CoNS
n = 54
Others
n = 589
No
growth
n = 445
Pathogens
n = 113
CoNS vs Others CoNS vs No growth CoNS vs Pathogens
n (%) n (%) n (%) n (%) OR (95%
CI)
aOR (95%
CI)a
OR (95%
CI)
aOR (95%
CI)a
OR (95%
CI)
aOR (95%
CI)b
History of fever 41
(75.9)
479 (81.5) 354 (79.6) 99 (88.4) 0.72 (0.37–
1.39)
0.60 (0.30–
1.18)
0.81 (0.42–
1.58)
0.70 (0.35–
1.39)
0.41 (0.18–
0.97)
0.43 (0.15–
1.25)
Temperature,
<36.5˚C >37.5˚C
8 (14.8)
30
(55.6)
62 (10.6)
363 (61.8)
51 (11.5)
261 (58.9)
9 (8.0)79
(69.9)
1.31 (0.53–
3.21)0.84
(0.44–1.58)
1.43 (0.56–
3.64)0.76
(0.39–1.46)
1.28 (0.52–
3.19)0.94
(0.50–1.79)
1.36 (0.53–
3.52)0.86
(0.44–1.69)
1.39 (0.44–
4.34)0.59
(0.28–1.26)
1.84 (0.43–
7.85)0.91
(0.35–2.34)
Cough 37
(68.5)
398 (67.8) 284 (64.0) 93 (83.0) 1.03 (0.57–
1.88)
0.90 (0.48–
1.68)
1.23 (0.67–
2.25)
1.11 (0.59–
2.09)
0.44 (0.21–
0.95)
0.41 (0.15–
1.12)
Respiratory
distress
39
(72.2)
385 (65.4) 272 (61.1) 93 (82.3) 1.38 (0.74–
2.56)
1.30 (0.69–
2.46)
1.65 (0.88–
3.09)
1.62 (0.85–
3.09)
0.56 (0.26–
1.20)
0.69 (0.26–
1.84)
Vomiting 16
(29.6)
215 (36.6) 169 (38.0) 38 (33.9) 0.73 (0.40–
1.34)
0.68 (0.36–
1.27)
0.69 (0.37–
1.27)
0.65 (0.34–
1.24)
0.82 (0.41–
1.66)
0.83 (0.37–
1.89)
Diarrhea 24
(44.4)
237 (40.3) 188 (42.3) 42 (37.5) 1.18 (0.68–
2.08)
1.15 (0.62–
2.12)
1.09 (0.62–
1.93)
1.07 (0.57–
2.02)
1.33 (0.69–
2.59)
1.52 (0.66–
3.46)
Inability to drink 2 (3.9) 7 (1.21) 5 (1.1) 2 (1.82) 3.27 (0.66–
16.20)
2.38 (0.45–
12.69)
3.48 (0.66–
18.41)
2.15 (0.36–
12.67)
2.16 (0.30–
15.78)
1.69 (0.14–
19.65)
Capillary refill
time,3 sec
2 (3.7) 36 (6.1) 26 (5.8) 10 (8.9) 0.59 (0.14–
2.52)
0.48 (0.11–
2.10)
0.62 (0.14–
2.69)
0.49 (0.11–
2.26)
0.39 (0.08–
1.86)
0.27 (0.05–
1.59)
Convulsions 2 (3.7) 44 (7.5) 24 (5.4) 16 (14.3) 0.48 (0.11–
2.02)
0.46 (0.10–
2.08)
0.67 (0.15–
2.94)
0.63 (0.13–
3.01)
0.23 (0.05–
1.04)
0.16 (0.03–
0.86)
Impaired
consciousness
9 (16.7) 141 (24.0) 100 (22.5) 37 (33.0) 0.63 (0.30–
1.33)
0.61 (0.28–
1.31)
0.69 (0.33–
1.46)
0.65 (0.29–
1.45)
0.41 (0.18–
0.92)
0.38 (0.15–
0.97)
a Adjusted for age, sex, blood volume, nutrition status, malaria, and year of admission.
b Adjusted for age, sex, blood volume, nutrition status, malaria, year, and clinical features with p0.1 at univariable regression (fever, cough, convulsions
and impaired consciousness).
https://doi.org/10.1371/journal.pone.0182354.t006
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to those with either known pathogens or no growth on blood culture. Comparison of CoNS to
presumed contaminants did not yield more information than the results we have presented as
mortality amongst children with SAM (aOR 0.55, 95%CI 0.25–1.17) and HIV-positive children
(aOR 0.83, 95%CI 0.15–4.47), and clinical features did not differ between the two groups.
There were limitations to our study. We did not routinely perform repeat blood cultures
when CoNS was isolated or undertake speciation. Our study principally examined blood cul-
tures taken at admission to hospital and therefore may not reflect hospital acquired infections
or settings where indwelling devices or invasive ventilation are used. Antibiotic treatment ini-
tiated at admission may have influenced outcomes amongst hospitalized children with CoNS
if they were sensitive to beta lactams. However, this treatment data was not available and we
were therefore not able to adjust for this in the multivariable analysis. We lacked confirmatory
PCR test results for HIV viral DNA for children aged<18 months. To mitigate this we con-
ducted a separate analysis adjusting for age (below and above 18 months old) (S3 Table and S4
Table), and results were similar to those obtained including all children with a positive HIV
antibody test.
In rural Kenya, although CoNS were common blood culture isolates amongst children with
SAM or a positive HIV antibody test, but there was no evidence that CoNS were commonly
clinically significant in either of these groups, nor to suggest that specific treatment is required
as standard practice.
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